Search research articles
Contact Us
Filters
Showing results (141-150 of 234) with videos related to
Page
of 24
Sort By:
Expert Review of Anticancer Therapy
|
February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis
Monica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials
Hendrik-Tobias Arkenau, Dirk Arnold, Jim Cassidy, et al.
Cancer Treatment Reviews
|
April 10, 2021
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients' data from 3 phase III studies
Lisa Salvatore, Emilio Bria, Isabella Sperduti, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 14, 2014
Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large German community-based observational cohort study
Alexander Stein, Volker Petersen, Mathias Schulze, et al.
Expert Review of Anticancer Therapy
|
July 19, 2018
Targeted therapy for metastatic colorectal cancer
Timothy J Price, Monica Tang, Peter Gibbs, et al.
Journal of Cancer Research and Clinical Oncology
|
April 13, 2018
MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach
Hans-Joachim Schmoll, Dirk Arnold, Aimery de Gramont, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
December 8, 2010
Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?
Claus Rödel, Dirk Arnold, Heinz Becker, et al.
BMC Cancer
|
February 12, 2016
Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study
Alexander Stein, Julia Quidde, Jan Klaus Schröder, et al.
BMC Cancer
|
August 1, 2015
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Alexander Stein, Dirk Arnold, John Bridgewater, et al.
Expert Review of Anticancer Therapy
|
August 21, 2014
Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013
Timothy J Price, Eva Segelov, Matthew Burge, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 234) with videos related to
Sort By:
Page
of 24
Expert Review of Anticancer Therapy
|
February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis
Monica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials
Hendrik-Tobias Arkenau, Dirk Arnold, Jim Cassidy, et al.
Cancer Treatment Reviews
|
April 10, 2021
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients' data from 3 phase III studies
Lisa Salvatore, Emilio Bria, Isabella Sperduti, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 14, 2014
Bevacizumab plus chemotherapy as first-line treatment for patients with metastatic colorectal cancer: results from a large German community-based observational cohort study
Alexander Stein, Volker Petersen, Mathias Schulze, et al.
Expert Review of Anticancer Therapy
|
July 19, 2018
Targeted therapy for metastatic colorectal cancer
Timothy J Price, Monica Tang, Peter Gibbs, et al.
Journal of Cancer Research and Clinical Oncology
|
April 13, 2018
MODUL-a multicenter randomized clinical trial of biomarker-driven maintenance therapy following first-line standard induction treatment of metastatic colorectal cancer: an adaptable signal-seeking approach
Hans-Joachim Schmoll, Dirk Arnold, Aimery de Gramont, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
December 8, 2010
Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?
Claus Rödel, Dirk Arnold, Heinz Becker, et al.
BMC Cancer
|
February 12, 2016
Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study
Alexander Stein, Julia Quidde, Jan Klaus Schröder, et al.
BMC Cancer
|
August 1, 2015
Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial
Alexander Stein, Dirk Arnold, John Bridgewater, et al.
Expert Review of Anticancer Therapy
|
August 21, 2014
Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013
Timothy J Price, Eva Segelov, Matthew Burge, et al.
Page
of 24